Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder

医学 右美托咪定 安慰剂 麻醉 随机对照试验 临床终点 情感障碍症 双相情感障碍 安慰剂对照研究 内科学 双盲 镇静 病理 替代医学 狂躁 锂(药物)
作者
Sheldon Preskorn,Scott L. Zeller,Leslie Citrome,Jeffrey S. Finman,Joseph F. Goldberg,Maurizio Fava,Rishi Kakar,Michael De Vivo,Frank D. Yocca,Robert Risinger
出处
期刊:JAMA [American Medical Association]
卷期号:327 (8): 727-727 被引量:61
标识
DOI:10.1001/jama.2022.0799
摘要

Importance

Acute agitation is common in patients with bipolar disorder and requires urgent management to relieve distress and to prevent escalation to aggressive behavior.

Objective

To evaluate the effect of orally absorbed, sublingual dexmedetomidine, a selective α2A-adrenergic receptor agonist on symptoms of acute agitation in patients with bipolar disorder.

Design, Setting, and Participants

Phase 3, randomized, double-blind, placebo-controlled trial conducted in 15 sites in the US with enrollment between February 24, 2020, and April 27, 2020, and final follow-up on May 21, 2020. A total of 380 adults with bipolar I or II disorder were randomized and 362 completed the study.

Interventions

Participants were randomized to 3 groups: sublingual dexmedetomidine 180 μg (n = 127), sublingual dexmedetomidine 120 μg (n = 127), or placebo (n = 126).

Main Outcomes and Measures

The primary efficacy end point was the mean change from baseline at 2 hours for the Positive and Negative Syndrome Scale-Excited Component (PEC) total score. The range of possible total scores is 5 (absence of agitation) to 35 (extremely severe). The secondary end point was the earliest time of a statistically significant change in PEC total score from baseline for the drug vs placebo. On the primary efficacy end point, to account for multiplicity associated with comparing 2 sublingual dexmedetomidine doses with placebo, the 2-sided significance level for each dose vs placebo was set at .025.

Results

Of 380 patients randomized (mean age, 45.6 years; 54.8% women; and 56.1% Black individuals), 378 (99.5%) self-administered the study medication and completed the study. Baseline agitation was mild to moderate, with an overall mean PEC total score of 18.0. Two hours after taking the medication, the mean changes from baseline in PEC total score were −10.4 for sublingual dexmedetomidine 180 μg, −9.0 for sublingual dexmedetomidine 120 μg, and −4.9 for placebo. Least-square mean differences from placebo in the sublingual dexmedetomidine groups at 2 hours were −5.4 (97.5% CI, −6.6 to −4.2) for 180 μg and −4.1 (97.5% CI, −5.3 to −2.9) for 120 μg (both dosesP < .001 vs placebo). Treatment effects began 20 minutes after taking the medication among patients in the sublingual dexmedetomidine groups (least-square mean difference for 180 μg, −1.1 [97.5% CI, −2.0 to −0.2];P = .007; for 120 μg, −1.0 [97.5% CI, −1.9 to −0.1];P = .009). Adverse events occurred in 35.7% of patients taking 180 μg of dexmedetomidine, 34.9% taking 120 μg, and 17.5% taking placebo. The most common adverse events (≥5%) in the respective 180 μg, 120 μg, and placebo groups were somnolence (21.4% and 20.6% vs 4.8%); dry mouth (4.8% and 7.1% vs 0.8%); hypotension (6.3% and 4.8% vs 0%); and dizziness (5.6% and 5.6% vs 0.8%).

Conclusions and Relevance

Among patients with mild to moderate agitation associated with bipolar disorder, treatment with a sublingual film formulation of dexmedetomidine 120 μg or 180 μg, compared with placebo, resulted in significantly greater reduction in the agitation score at 2 hours. Further research is needed to understand the spectrum of patients for whom this treatment would be effective and feasible and to better understand the clinical importance of the observed effect size.

Trial Registration

ClinicalTrials.gov Identifier:NCT04276883
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_nvkv4Z完成签到,获得积分10
刚刚
阳光的青槐完成签到,获得积分10
刚刚
刚刚
华仔应助YHYHYH采纳,获得10
刚刚
1秒前
漫漫完成签到,获得积分10
1秒前
田様应助凌露采纳,获得10
1秒前
2秒前
3秒前
3秒前
发angew完成签到,获得积分10
3秒前
小凯完成签到,获得积分10
4秒前
彭于晏应助没事发发呆采纳,获得10
4秒前
5秒前
Veronica发布了新的文献求助10
5秒前
Aulalala发布了新的文献求助30
6秒前
幽默雅香完成签到 ,获得积分10
6秒前
6秒前
dongkk发布了新的文献求助10
7秒前
7秒前
勤恳立轩应助赵宇宙采纳,获得10
7秒前
无花果应助凌凌凌采纳,获得10
7秒前
8秒前
赘婿应助麦克雷采纳,获得30
8秒前
WX完成签到,获得积分10
8秒前
8秒前
天天快乐应助小凯采纳,获得10
9秒前
qiyr发布了新的文献求助20
9秒前
美满秋莲目完成签到,获得积分10
10秒前
喵喵喵完成签到,获得积分10
11秒前
12秒前
干一口敌敌畏完成签到,获得积分10
12秒前
JYT发布了新的文献求助10
13秒前
pipge完成签到,获得积分20
13秒前
lkxpsy发布了新的文献求助30
13秒前
任小萱发布了新的文献求助10
14秒前
今后应助xu采纳,获得10
14秒前
善学以致用应助雪落采纳,获得10
14秒前
14秒前
15秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Conference Record, IAS Annual Meeting 1977 820
England and the Discovery of America, 1481-1620 600
Teaching language in context (Third edition) by Derewianka, Beverly; Jones, Pauline 550
電気学会論文誌D(産業応用部門誌), 141 巻, 11 号 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3583231
求助须知:如何正确求助?哪些是违规求助? 3152508
关于积分的说明 9492920
捐赠科研通 2854882
什么是DOI,文献DOI怎么找? 1569373
邀请新用户注册赠送积分活动 735182
科研通“疑难数据库(出版商)”最低求助积分说明 721082